Changes in Epidemiological Characteristics in Children with Mycoplasma pneumoniae Seropositivity in Southwest China from 2022 to 2023
Open Access
- 9 May 2026
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (10) , 3655
Abstract
Background: Mycoplasma pneumoniae (MP) is an important pathogen responsible for community-acquired respiratory infections in children. Global surveillance during the COVID-19 pandemic revealed a marked decline in MP activity. However, beginning in early summer 2023, multiple regions across China reported an unexpected resurgence of MP infections, highlighting the need for detailed epidemiological analysis. Objective: This study aimed to characterize the epidemiological features of MP seropositivity among children in Chengdu, southwest China, and to compare its patterns between the COVID-19 pandemic and post pandemic periods. Methods: A retrospective analysis was conducted on MP testing data from 39,552 children with acute respiratory infections who were treated at West China Second University Hospital, Sichuan University, between January 2022 and December 2023. Results: Both the number of MP tests conducted and the seropositivity rate were significantly lower during the pandemic period than during the post pandemic phase. Compared with male children, female children were more susceptible to MP seropositivity. In terms of age distribution, seropositivity rates were highest among toddlers (1–3 years) and school-aged children (6–14 years). During the pandemic period (2022), MP antibody-positive cases were observed mainly between January and July, whereas in the post pandemic phase (2023), the epidemic peak shifted from June to December. Conclusions: In this single-centre study in Chengdu, nonpharmaceutical interventions (NPIs) implemented during the COVID-19 pandemic was associated with a marked reduction in MP transmission. After these restrictions were lifted, a rebound in MP antibody positivity was observed among children in Chengdu, compared to the NPI period (2022), the post-NPI period (2023) showed a later seasonal peak, which may represent a delayed return to pre-pandemic patterns. Continuous strengthening of MP surveillance is necessary to provide early warning of potential resurgences and outbreak risks.Keywords
This publication has 30 references indexed in Scilit:
- Post-COVID-19 resurgence of Mycoplasma pneumoniae infections in French children (ORIGAMI): a retrospective and prospective multicentre cohort studyThe Lancet Infectious Diseases, 2025
- Mycoplasma pneumoniae MLST detected in the upsurge of pneumonia during the 2023 to 2024 winter season in the NetherlandsScientific Reports, 2025
- Performance of the World Health Organization (WHO) severe acute respiratory infection (SARI) case definitions in hospitalized children and youth: cross-sectional studyThe Lancet Regional Health - Americas, 2025
- Mycoplasma pneumoniae incidence, phenotype, and severity in children and adolescents in Denmark before, during, and after the COVID-19 pandemic: a nationwide multicentre population-based cohort studyThe Lancet Regional Health - Europe, 2024
- Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictionsThe Lancet Microbe, 2023
- Clinical features of severe Mycoplasma pneumoniae pneumonia with pulmonary complications in childhood: A retrospective studyPediatric Pulmonology, 2023
- Mycoplasma pneumoniae: gone forever?The Lancet Microbe, 2023
- Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020Emerging Microbes & Infections, 2022
- Etiological and epidemiological features of acute respiratory infections in ChinaNature Communications, 2021
- Incidence of respiratory viruses in peruvian children with acute respiratory infectionsJournal of Medical Virology, 2015